Bacteroides ovatus for Relieving Endotoxin Infection and Application thereof
AssigneeJiangnan University
InventorsWei CHEN, Qixiao ZHAI, Huizi TAN, Wenwei LU, Fengwei TIAN, Jianxin ZHAO, Hao ZHANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeJiangnan University
InventorsWei CHEN, Qixiao ZHAI, Huizi TAN, Wenwei LU, Fengwei TIAN, Jianxin ZHAO, Hao ZHANG
Estimating the term…
The disclosure discloses Bacteroides ovatus for relieving endotoxin infection and application thereof, and belongs to the technical field of microorganisms. The Bacteroides ovatus CCFM1021 of the disclosure has low immunogenicity, and can reduce the content of pro-inflammatory factors and increase the concentration of anti-inflammatory factors in the blood of mice infected with endotoxin, up-regulate the number of Foxp3+ regulatory T cells and stabilize the composition of the intestinal microbiota. A pharmaceutical composition of the Bacteroides ovatus CCFM1021 for relieving endotoxin infection has broad application prospects.
A composition comprising a bacterium of Bacteroides ovatus with a preservation number of GDMCC No:
Dependencies are inferred from the claim text.